Author

David Paladino

Assistant Professor, University at Buffalo School of Pharmacy - Cited by 1,193 - Pharmacoepidemiology - Health Services Research - Pharmaceutical Outcomes

Biography

Dr. David Paladino is currently working at Cancer Biology Department. David Paladino  is research interests includes Cancer Biology in Pharmacophore-based 3D-QSAR. David Paladino  serving as an editorial member and reviewer of several international reputed journals. David Paladino  has successfully completed his Administrative responsibilities. David Paladino  has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the Nationwide Readmissions Database
DM Jacobs, K Noyes, J Zhao, W Gibson, TF Murphy, S Sethi, ...ANNALS OF THE AMERICAN THORACIC SOCIETY 15 (7), 837-845, 2018201
95
2018
Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study
E Hart, TE Dunn, S Feuerstein, DM JacobsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (4 …, 2019201
65
2019
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review
DM Jacobs, MC Safir, D Huang, F Minhaj, A Parker, GG RaoAnnals of clinical microbiology and antimicrobials 16 (1), 1-12, 2017201
53
2017
Potentially inappropriate medications are associated with increased healthcare utilization and costs
CM Clark, AL Shaver, LA Aurelio, S Feuerstein, RG Wahler Jr, CJ Daly, ...Journal of the American Geriatrics Society 68 (11), 2542-2550, 2020202
47
2020
Early administration of adjuvant β‐lactam therapy in combination with vancomycin among patients with methicillin‐resistant Staphylococcus aureus bloodstream infection: a …
AM Casapao, DM Jacobs, DR Bowers, ND Beyda, TJ Dilworth, ...Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (11 …, 2017201
46
2017
Impact of Pseudomonas aeruginosa Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort
DM Jacobs, HM Ochs-Balcom, K Noyes, J Zhao, WY Leung, CY Pu, ...Open Forum Infectious Diseases 7 (1), ofz546, 2020202
34
2020
Overtreatment of asymptomatic candiduria among hospitalized patients: a multi-institutional study
DM Jacobs, TJ Dilworth, ND Beyda, AM Casapao, DR BowersAntimicrobial agents and chemotherapy 62 (1), 10.1128/aac. 01464-17, 2018201
32
2018
A systematic review of the impact of antifungal stewardship interventions in the United States
E Hart, M Nguyen, M Allen, CM Clark, DM JacobsAnnals of clinical microbiology and antimicrobials 18, 1-10, 2019201
31
2019
Antibiotic prescribing for acute respiratory tract infections in the United States outpatient setting
AL Shaver, DM Jacobs, MJ LaMonte, K NoyesBMC Family Practice 20 (1), 1-10, 2019201
29
2019
Lower airway bacterial colonization patterns and species-specific interactions in chronic obstructive pulmonary disease
DM Jacobs, HM Ochs-Balcom, J Zhao, TF Murphy, S SethiJournal of Clinical Microbiology 56 (10), 10.1128/jcm. 00330-18, 2018201
25
2018
Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?
DM Jacobs, U Pandit, S SethiCurrent Opinion in Infectious Diseases 32 (2), 143-151, 2019201
23
2019
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis
I Puzanov, P Subramanian, YV Yatsynovich, DM Jacobs, MR Chilbert, ...Journal for Immunotherapy of Cancer 9 (6), 2021202
22
2021
Addressing social determinants of health in community pharmacy: innovative opportunities and practice models
AA Foster, CJ Daly, T Logan, R Logan Jr, H Jarvis, J Croce, Z Jalal, ...Journal of the American Pharmacists Association 61 (5), e48-e54, 2021202
19
2021
Socio-demographic and-economic factors associated with 30-day readmission for conditions targeted by the hospital readmissions reduction program: a population-based study
F Murray, M Allen, CM Clark, CJ Daly, DM JacobsBMC Public Health 21, 1-13, 2021202
15
2021
Impact of community pharmacist interventions with managed care to improve medication adherence
CJ Daly, K Verrall, DM JacobsJournal of Pharmacy Practice 34 (5), 694-702, 2021202
15
2021
Pharmacist-led transitions-of-care services in primary care settings: opportunities, experiences, and challenges
E Slazak, C Cardinal, S Will, CM Clark, CJ Daly, DM JacobsJournal of the American Pharmacists Association 60 (3), 443-449, 2020202
14
2020
Trends in fall‐related mortality and fall risk increasing drugs among older individuals in the United States, 1999–2017
AL Shaver, CM Clark, M Hejna, S Feuerstein, RG Wahler Jr, DM JacobsPharmacoepidemiology and drug safety 30 (8), 1049-1056, 2021202
13
2021
Community pharmacists’ perceptions of patient care services within an enhanced service network
CJ Daly, B Quinn, A Mak, DM JacobsPharmacy 8 (3), 172, 2020202
12
2020
Incidence and risk factors for healthcare utilisation among patients discharged on outpatient parenteral antimicrobial therapy
DM Jacobs, WY Leung, D Essi, W Park, A Shaver, J Claus, C Ruh, ...Epidemiology & Infection 146 (6), 782-787, 2018201
10
2018
Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: Does β-Lactam Class Matter?
TJ Dilworth, AM Casapao, OM Ibrahim, DM Jacobs, DR Bowers, ...Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 02211-18, 20120
9
2019

Referred From: https://scholar.google.com/citations?user=E9CP9xAAAAAJ&hl=en

Cited by
Citations 1193
h-index 22
i10-index 34
Recommended Journals
Open Access Journals